12:00 AM
 | 
May 30, 2016
 |  BC Week In Review  |  Company News  |  Deals

XenoPort, Arbor Pharmaceuticals deal

Specialty pharma Arbor will acquire XenoPort for $7.03 per share in a cash deal the companies say values XenoPort at $467 million. The price is...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >